These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 24061224)

  • 1. Stem cells: No limits to iPS cells?
    Baumann K
    Nat Rev Mol Cell Biol; 2013 Oct; 14(10):610. PubMed ID: 24061224
    [No Abstract]   [Full Text] [Related]  

  • 2. Stem cells: Reprogramming in situ.
    De Los Angeles A; Daley GQ
    Nature; 2013 Oct; 502(7471):309-10. PubMed ID: 24025771
    [No Abstract]   [Full Text] [Related]  

  • 3. Reprogramming the cardiac field.
    Willems E; Mercola M
    Circ Res; 2014 Jan; 114(3):409-11. PubMed ID: 24481840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reprogramming can be a transforming experience.
    Hobbs RM; Polo JM
    Cell Stem Cell; 2014 Mar; 14(3):269-71. PubMed ID: 24607400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reprogramming in vivo produces teratomas and iPS cells with totipotency features.
    Abad M; Mosteiro L; Pantoja C; Cañamero M; Rayon T; Ors I; Graña O; Megías D; Domínguez O; Martínez D; Manzanares M; Ortega S; Serrano M
    Nature; 2013 Oct; 502(7471):340-5. PubMed ID: 24025773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reprogramming rewarded: the 2012 Nobel Prize for Physiology or Medicine awarded to John Gurdon and Shinya Yamanaka.
    Johnson MH; Cohen J
    Reprod Biomed Online; 2012 Dec; 25(6):549-50. PubMed ID: 23211094
    [No Abstract]   [Full Text] [Related]  

  • 7. FoxO3a contributes to the reprogramming process and the differentiation of induced pluripotent stem cells.
    Wang Y; Tian C; Zheng JC
    Stem Cells Dev; 2013 Nov; 22(22):2954-63. PubMed ID: 23815557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Robust reprogramming of Ataxia-Telangiectasia patient and carrier erythroid cells to induced pluripotent stem cells.
    Bhatt N; Ghosh R; Roy S; Gao Y; Armanios M; Cheng L; Franco S
    Stem Cell Res; 2016 Sep; 17(2):296-305. PubMed ID: 27596957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of electrophysiologically functional cardiomyocytes from mouse induced pluripotent stem cells.
    Wang H; Xi Y; Zheng Y; Wang X; Cooney AJ
    Stem Cell Res; 2016 Mar; 16(2):522-30. PubMed ID: 26972055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of induced pluripotent stem cells by efficient reprogramming of adult bone marrow cells.
    Kunisato A; Wakatsuki M; Kodama Y; Shinba H; Ishida I; Nagao K
    Stem Cells Dev; 2010 Feb; 19(2):229-38. PubMed ID: 19558219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem cells: iPS cells under attack.
    Apostolou E; Hochedlinger K
    Nature; 2011 Jun; 474(7350):165-6. PubMed ID: 21654792
    [No Abstract]   [Full Text] [Related]  

  • 12. Generation of Mouse-Induced Pluripotent Stem Cells by Lentiviral Transduction.
    Liu X; Chen J; Firas J; Paynter JM; Nefzger CM; Polo JM
    Methods Mol Biol; 2019; 1940():63-76. PubMed ID: 30788818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induced pluripotent stem cells and their potential for basic and clinical sciences.
    Ye L; Swingen C; Zhang J
    Curr Cardiol Rev; 2013 Feb; 9(1):63-72. PubMed ID: 22935022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excision of reprogramming transgenes improves the differentiation potential of iPS cells generated with a single excisable vector.
    Sommer CA; Sommer AG; Longmire TA; Christodoulou C; Thomas DD; Gostissa M; Alt FW; Murphy GJ; Kotton DN; Mostoslavsky G
    Stem Cells; 2010 Jan; 28(1):64-74. PubMed ID: 19904830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reprogramming of somatic cells after fusion with induced pluripotent stem cells and nuclear transfer embryonic stem cells.
    Sumer H; Jones KL; Liu J; Heffernan C; Tat PA; Upton KR; Verma PJ
    Stem Cells Dev; 2010 Feb; 19(2):239-46. PubMed ID: 19637940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial Disease-Specific Induced Pluripotent Stem Cell Models: Generation and Characterization.
    Zhang X; Li S; Yang W; Pan H; Qin D; Zhu X; Yan Q
    Methods Mol Biol; 2016; 1353():323-42. PubMed ID: 25646615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zscan4 promotes genomic stability during reprogramming and dramatically improves the quality of iPS cells as demonstrated by tetraploid complementation.
    Jiang J; Lv W; Ye X; Wang L; Zhang M; Yang H; Okuka M; Zhou C; Zhang X; Liu L; Li J
    Cell Res; 2013 Jan; 23(1):92-106. PubMed ID: 23147797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing Induced Pluripotent Stem Cell Generation by MicroRNA.
    Dang J; Rana TM
    Methods Mol Biol; 2016; 1357():71-84. PubMed ID: 25687299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induced pluripotent stem cells: from derivation to application in biochemical and biomedical research.
    Novosadova EV; Grivennikov IA
    Biochemistry (Mosc); 2014 Dec; 79(13):1425-41. PubMed ID: 25749158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lessons from expanded potential of embryonic stem cells: Moving toward totipotency.
    Le R; Huang Y; Zhao A; Gao S
    J Genet Genomics; 2020 Mar; 47(3):123-130. PubMed ID: 32305172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.